| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/01/2004 | CN1164579C Thiazole and oxazole derivatives and their pharmaceutical use |
| 09/01/2004 | CN1164574C Phenoxypropylamine compounds |
| 09/01/2004 | CN1164334C Sustained release formulation of peptide |
| 09/01/2004 | CN1164328C IL6RIL6 chimera for treatment of neurodegenerative diseases |
| 09/01/2004 | CN1164326C Deoxidation type glutathione lozenge |
| 09/01/2004 | CN1164297C Use of kudzu root ,kudzu root flavone and puerarin for prevention and cure of osteoporosis |
| 08/31/2004 | US6784314 Process for producing amine derivatives |
| 08/31/2004 | US6784294 Reacting a pyridine- sulfanamide derivative with an amine to open the ring containing sulfur, oxygen and nitrogen atoms to form n1-(2'-pyridyl)-1,2-alkanediamine sulfamic acid, further hydrogenation and acid hydrolysis |
| 08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 08/31/2004 | US6784202 Cubane derivatives as metabotropic glutamate receptor agonists or antagonists and process for their preparation |
| 08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/31/2004 | US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784192 Na+ channel inhibitory action is useful for therapy and prevention for example, arrhythmia, various neuralgias and analgesic |
| 08/31/2004 | US6784187 8-carboxamido-2,6-methano-3-benzazocines |
| 08/31/2004 | US6784186 Opiods which have less activity within the central nervous system, thus having fewer undesirable side-effects |
| 08/31/2004 | US6784183 Diphenylurea compounds |
| 08/31/2004 | US6784181 Ligands for the delta receptor |
| 08/31/2004 | US6784180 Piperidines derivatives and their use as serotonin receptor antagonists |
| 08/31/2004 | US6784175 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6784172 Acylation of 1,4-benzodiazepines, followed by nitrosation, reduction, imination with a cyclopentanone, cyclization, reduction and deacylation |
| 08/31/2004 | US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783952 Deleting portion of eukaryotic nucleotide sequence encoding cerebral cortical voltage-dependent calcium channel alpha 2 subunit yielding soluble secreted protein retaining affinity for (3h)gabapentin |
| 08/31/2004 | US6783935 Genetic polymorphism of MxA protein and use thereof |
| 08/31/2004 | US6783753 Rapidly produces peak plasma concentrations of the compound. |
| 08/31/2004 | CA2098076C Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates |
| 08/29/2004 | WO2004035047A1 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity |
| 08/29/2004 | CA2501172A1 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity |
| 08/26/2004 | WO2004072643A2 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r) |
| 08/26/2004 | WO2004072305A2 Atlastin |
| 08/26/2004 | WO2004072078A1 Pyrazolotriazine derivatives, methods for production and uses thereof |
| 08/26/2004 | WO2004072071A1 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/26/2004 | WO2004072067A1 Benzofurane derivatives and the use of the same as antidepressants and anxiolytics |
| 08/26/2004 | WO2004072050A1 Heterocyclic compounds useful as nurr-1 activators |
| 08/26/2004 | WO2004072037A1 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 08/26/2004 | WO2004072034A1 Piperidine-benzenesulfonamide derivatives |
| 08/26/2004 | WO2004072029A2 Pyrazolopyridazines useful as inhibitors of protein kinases |
| 08/26/2004 | WO2004072020A1 Hydroxy-tetrahydro-naphthalenylurea derivatives |
| 08/26/2004 | WO2004071529A2 Uses of anti-insulin-like growth factor i receptor antibodies |
| 08/26/2004 | WO2004071528A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 08/26/2004 | WO2004071517A2 Uses of il-23 related reagents |
| 08/26/2004 | WO2004071513A1 Use of r-10-hydroxy-10, 11-dihydro-carbamazepine in neuropathic pain |
| 08/26/2004 | WO2004071512A1 Application of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt as medicament |
| 08/26/2004 | WO2004071509A1 Oligodendrocyte differentiation promoters |
| 08/26/2004 | WO2004071507A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 08/26/2004 | WO2004071501A1 Enantiomeric amphetamine compositions for the treatment of adhd |
| 08/26/2004 | WO2004071435A2 Enhanced Bioavailability Using Laser Resonant Homogenization |
| 08/26/2004 | WO2004071416A2 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 08/26/2004 | WO2004071413A2 Method and composition for potentiating an opiate analgesic |
| 08/26/2004 | WO2004071395A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox1r (ox1r) |
| 08/26/2004 | WO2004071392A2 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 08/26/2004 | WO2004071381A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
| 08/26/2004 | WO2004071380A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds |
| 08/26/2004 | WO2004071378A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 08/26/2004 | WO2004071152A2 Use of s-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders |
| 08/26/2004 | WO2004058679A3 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 08/26/2004 | WO2004047744A3 3-heterocyclic benzylamide derivatives as potassium channel openers |
| 08/26/2004 | WO2004028548A3 Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents |
| 08/26/2004 | WO2004011464A3 Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 08/26/2004 | WO2004004653A3 Methods for treating psychosis associated with interferon-alpha therapy |
| 08/26/2004 | WO2003101402A3 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 08/26/2004 | WO2003094965A8 Modulation of neural stem cells with s1p or lpa receptor agonists |
| 08/26/2004 | WO2003088905A3 Compositions and minimally invasive methods for treating incomplete tissue repair |
| 08/26/2004 | WO2003079976A3 A substance with sedative effect |
| 08/26/2004 | WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/26/2004 | WO2003055440A3 Compositions and methods for the treatement of immune related diseases |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/26/2004 | US20040167358 Method and reagents for N-alkylating ureides |
| 08/26/2004 | US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 08/26/2004 | US20040167336 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
| 08/26/2004 | US20040167335 For therapy and prophylaxis of herpes viral infections |
| 08/26/2004 | US20040167228 aerosols containing atenolol, pindolol, esmolol, propranolol, or metoprolol that are used in inhalation therapy |
| 08/26/2004 | US20040167224 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 08/26/2004 | US20040167217 Brain disorders; central nervous system disorders; antiischemic agents; hyperglycemic agents; anoxia; poisoning; using curcimim, caffeic acid and phenethyl ester |
| 08/26/2004 | US20040167216 Carbidopa prodrugs and derivatives, and compositions and uses thereof |
| 08/26/2004 | US20040167210 Crystalline base of citalopram |
| 08/26/2004 | US20040167209 Antidepressants; anxiolytic agents |
| 08/26/2004 | US20040167186 Use of certain crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide in treating epilepsy |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167171 Prevention, therapy of neurodegenerative disease; diffusion through brain, blood barrier; Alzheimer's, Parkinson's Huntington's diseases, Amyotrophic lateral sclerosis |
| 08/26/2004 | US20040167166 Amino-piperidine derivatives |
| 08/26/2004 | US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders |
| 08/26/2004 | US20040167158 Heterocyclic compounds for the treatment of migraine |
| 08/26/2004 | US20040167155 Treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, diabetes and autoimmune diseases |
| 08/26/2004 | US20040167149 Aryl fused azapolycyclic compounds |
| 08/26/2004 | US20040167145 moderator of cholinergic agent; mixture of acetylcholinesterase inhibitors and opioiod receptor blockers |
| 08/26/2004 | US20040167143 High speed metabolism; antiepileptic agents; anesthetics; central nervous system disorders; anxiolytic agents |
| 08/26/2004 | US20040167142 Pyrimidinone compounds |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167138 Antiischemic agents; brain disorders |
| 08/26/2004 | US20040167133 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/26/2004 | US20040167127 atherosclerosis; antiarthritic agents; antidiabetic agents; cardiovascular disorders; autoimmune diseases; multiple sclerosis; chronic obstructive pulmonary disease |
| 08/26/2004 | US20040167125 such as sertindole, quetiapine and ziprasidone; use of combination to treat schizophrenia; synergistic mixture gives a more more rapid decrease in schizophrenic symptomology improving patient compliance |
| 08/26/2004 | US20040167122 Central nervous system disorders; anxiolytic agents; neurodegenerative disorders; obsessive compulsive disorders; schizophrenia; antidepressants; alzheimer's disease; neuropathic pain; stroke |
| 08/26/2004 | US20040167118 Novel diarylalkene derivatives and novel diarylalkane derivatives |
| 08/26/2004 | US20040167075 Diagnosis, therapy od Alzheimer's disease; blocking psychological conditions |
| 08/26/2004 | US20040167065 human transferases and polynucleotides which identify and encode them; expression vectors, host cells, antibodies, agonists, and antagonists; diagnosing, treating, or preventing disorders associated with aberrant expression of the transferases |